A pilot study of ONC 201 maintenance therapy in acute myeloid leukemia and myelodysplastic syndrome after an allogeneic hematopoietic stem cell transplant
Categories (click each to see list of all clinical trials associated with that category): BMT/GVHD (ONC), Leukemia/MDS/MPD (ONC)
Current Status: Open
Phase: N/A
Principal Investigator: Bhatt, Vijaya
Contact Information:
Penny Hardiman, RN
402-559-4135
penny.hardiman@unmc.edu
Eligibility: https://clinicaltrials.gov/study/NCT03932643?term=NCT03932643&rank=1
Summary
Primary objectives:
1. The rate of dose limiting toxicities during the first cycle (among the dose escalating cohort)
2. The number of grade ≥3 toxicities
Secondary objectives:
1. Number of toxicities (all grades) associated with the use of ONC 201 during the entire duration of maintenance therapy with ONC 201